Serum Anti-Müllerian Hormone as a Predictor of Polycystic Ovarian Syndrome Among Women of Reproductive Age

    February 2022 in “ Research Square (Research Square) ”
    Muhammad Salman Butt, Javeria Saleem, Sobia Aiman … Florian Fischer

    Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

    Studysummary This study concluded that an elevated serum Anti-Müllerian Hormone level is a strong predictor for diagnosing Polycystic Ovarian Syndrome among women of reproductive age with characteristic features of the condition.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on researchsquare.com →
    Discuss this study in the Community →

    Related research 1

    1. Effectiveness of Combined Oral Contraceptives in Women with Polycystic Ovary Syndrome Kazan medical journal · 2011